Author

Mary J. H. J. Palmen

Observed names: M J H J PALMEN, M J H J Palmen, M PALMEN, M Palmen, M. J. H. J. PALMEN, M. J. H. J. Palmen, M. PALMEN, M. Palmen, Mary Palmen

Institution: Aurinia (Canada)

Observed institutions: Mayo Clinic, Leiden University Medical Center, Vifor Pharma (Switzerland), Aurinia (Canada), Shire (United Kingdom), Vrije Universiteit Amsterdam, Wageningen University & Research

OpenAlex ID: A5112336147

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

1998 · L A Dieleman, M J H J Palmen, et al. · Clinical & Experimental Immunology · 1,166

Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis

2006 · Michael A. Kamm, William J. Sandborn, et al. · Gastroenterology · 352

Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats

1995 · M J H J PALMEN, C D DIJKSTRA, et al. · Clinical & Experimental Immunology · 99

Once daily MMX mesalazine for the treatment of mild‐to‐moderate ulcerative colitis: a phase II, dose‐ranging study

2006 · G. D'HAENS, D. HOMMES, et al. · Alimentary Pharmacology & Therapeutics · 83

PDF

Characterization of the mucosal cell‐mediated immune response in IL‐2 knockout mice before and after the onset of colitis

1997 · S. A. C. MCDONALD, M. J. H. J. PALMEN, et al. · Immunology · 76

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer

2001 · Sjoerd H. van der Burg, Karin de Cock, et al. · European Journal of Immunology · 59

PDF

Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis

1995 · M J H J Palmen, L A Dieleman, et al. · Clinical & Experimental Immunology · 38

Effects of inoculum route and dose on the immune response of common carp, Cyprinus carpio to the blood parasite, Trypanoplasma borreli

1993 · Simon R.M. Jones, Mary Palmen, et al. · Veterinary Immunology and Immunopathology · 35

Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis*

2011 · Sunanda Kane, Seymour Katz, et al. · Inflammatory Bowel Diseases · 30

Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia

2020 · Yanhua Ding, Xiaoxue Zhu, et al. · Clinical Therapeutics · 20

CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells

1998 · M J H J Palmen, O L C Wijburg, et al. · Clinical & Experimental Immunology · 19

Effects of Local Budesonide Treatment on the Cell-Mediated Immune Response in Acute and Relapsing Colitis in Rats

1998 · Mary J. H. J. Palmen, Levinus A. Dieleman, et al. · Digestive Diseases and Sciences · 15

Anti-inflammatory effect of apocynin, a plant-derived NADPH oxidase antagonist, in acute experimental colitis

1995 · M PALMEN, C BEUKELMAN, et al. · The Netherlands Journal of Medicine · 12

Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease

2008 · William Knebel, Mary Palmen, et al. · The Journal of Clinical Pharmacology · 9

A Pharmacokinetic and Scintigraphic Comparison of MMX™ mesalamine and Delayed-Release mesalamine

2008 · Heather Wray, Raymond Joseph, et al. · The American Journal of Gastroenterology · 7

FC054: Voclosporin for Lupus Nephritis: Results of the Two-Year Aurora 2 Continuation Study

2022 · Y.K.O. Teng, Amit Saxena, et al. · Nephrology Dialysis Transplantation · 4

Leukocyte migration in experimental inflammatory bowel disease

1997 · E. P. Van Rees, M. J. H. J. Palmen, et al. · Mediators of Inflammation · 3

PDF

Voclosporin Is Effective in Achieving Complete Renal Response in Severe Lupus Nephritis

2021 · Hanni Menn-Josephy, Matt Truman, et al. · Journal of the American Society of Nephrology · 2

P394 Pooled clinical trial analysis of MMX mesalazine safety: Focus on 4.8 g/d dose long-term exposure

2014 · S. Da Silva Sanchez, M. Palmen, et al. · Journal of Crohn s and Colitis · 1

PDF

P353 MMX® a mesalazine and long-term safety: A pooled analysis

2012 · D. Solomon, K. Paridaens, et al. · Journal of Crohn s and Colitis · 1

PDF

Pooled Safety Analysis of Long-term MMX®,a Mesalamine Administration

2011 · Dory Solomon, Kristine Paridaens, et al. · Inflammatory Bowel Diseases · 1

W1328 MMX® Mesalamine 2.4g/Day Maintains Clinical Remission in Patients With Mild-to-Moderate Ulcerative Colitis, Irrespective of Prior Treatment

2010 · Sunanda V. Kane, Dory M. Solomon, et al. · Gastroenterology · 1

Combined pharmacokinetic and scintigraphic analyses for the comparison of 5-ASA release profiles from MMX™ mesalamine and another delayed-release mesalamine formulation

2008 · H Wray, R Joseph, et al. · Inflammatory Bowel Diseases · 1

Combined pharmacokinetic and scintigraphic analyses for the comparison of 5-ASA release profiles from MMXTM mesalamine and another delayed-release mesalamine formulation

2008 · H Wray, R Joseph, et al. · Inflammatory Bowel Diseases · 1

Non-Lymphoid Cells in Acute and Chronic Experimental Inflammatory Bowel Disease

1994 · Mary J. H. J. Palmen, Marja B. van der Ende, et al. · Advances in experimental medicine and biology · 1

Works count: 34

Citation count: 2,036

H-index: 12

I10-index: 13